Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults’ Perspectives
Sexual and gender minority (SGM) populations remain at disproportionate risk of HIV infection. Despite the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV, PrEP uptake has been slow.
To identify barriers and facilitators of PrEP access by examining SGM patients’ experiences with accessing health care systems and engaging with providers about PrEP in a variety of practice settings.
Semi-structured, individual, qualitative interviews.
Twenty-seven sexual and gender minority adults residing in Oregon.
Interviews were audio-recorded, transcribed, and analyzed using thematic analysis.
We identified three main themes. Participants described the centrality of patient-provider relationships to positive experiences around PrEP, the necessity of personally advocating to access PrEP, and the experience of system-level barriers to PrEP access. Participants also made several suggestions to improve PrEP access including improving provider engagement with SGM patients, encouraging providers to initiate conversations about PrEP, and increasing awareness of medication financial support.
In order to reduce HIV disparities, improving PrEP access will require additional efforts by providers and resources across health care settings to reduce barriers. Interventions to improve provider education about PrEP and provider communication skills for discussing sexual health are needed. Additionally, there should be system-level improvements to increase coordination between patients, providers, pharmacies, and payers to facilitate PrEP access and uptake.
KEY WORDSprevention HIV/AIDS qualitative research patient preferences doctor-patient relationships
We thank the participants and the nPEP/PrEP stakeholder group, particularly Miguel D. Carreon, FNP-C, DNP, for their insights and expertise that greatly assisted the research.
This project was supported by Oregon AIDS Education and Training Center at Portland Veterans Affairs Research Foundation and grant number K12HS022981 from the Agency for Healthcare Research and Quality.
Compliance with Ethical Standards
The Portland State University Institutional Review Board approved this study.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the Oregon AIDS Education and Training Center at Portland Veterans Affairs Research Foundation and Agency for Healthcare Research and Quality.
- 1.Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveill Suppl Rep. 2018;23(1).Google Scholar
- 2.Gilead. U.S. Food and Drug Administration approves Gilead’s Truvada® for reducing the risk of acquiring HIV. Available at: https://www.gilead.com/news/press-releases/2012/7/us-food-and-drug-administration-approves-gileads-truvada-for-reducing-the-risk-of-acquiring-hiv. Accessed November 13, 2018.Google Scholar
- 8.Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update: a clinical practice guideline. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Accessed November 13, 2018.
- 10.Okwundu CI, Uthman OA, Okoromah CAN. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev. 2012;(7):CD007189.Google Scholar
- 11.National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention. HIV prevention pill not reaching most Americans who could benefit - especially people of color. Available at: https://www.cdc.gov/nchhstp/newsroom/2018/croi-2018-PrEP-press-release.html. Accessed November 13, 2018.
- 20.Hannaford A, Lipshie-Williams M, Starrels JL, et al. The use of online posts to identify barriers to and facilitators of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men: a comparison to a systematic review of the peer-reviewed literature. AIDS Behav. 2018;22(4):1080–1095.CrossRefGoogle Scholar
- 40.U.S. Preventive Services Task Force. Draft recommendation statement: Prevention of human immunodeficiency virus (HIV) infection: pre-exposure prophylaxis. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis. Accessed January 30, 2019.
- 47.Krakower DS, Ware NC, Maloney KM, Wilson IB, Wong JB, Mayer KH. Differing experiences with pre-exposure prophylaxis in Boston among lesbian, gay, bisexual, and transgender specialists and generalists in primary care: implications for scale-up. AIDS Patient Care STDS. 2017;31(7):297–304.CrossRefGoogle Scholar
- 55.Institute of Medicine. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. Washington, D.C.: The National Academies Press; 2011.Google Scholar
- 58.National Minority AIDS Council. National HIV and PrEP Navigation Landscape Assessment. Available from: http://www.nmac.org/wp-content/uploads/2017/11/National-HIV-and-PrEP-Navigation-Landscape-Assessment-Report.pdf. Accessed November 13, 2018.